Kringle Pharma, Inc.

2026/10/02 18:47 Updated
Market Cap: $24.8M (¥3.9B)
Stock Price: $3.07 (¥484)
Exchange Rate: 1 USD = ¥157.73

Notice of Public Disclosure of Registration Information for Phase III Additional Clinical Trial of HGF (Hepatocyte Growth Factor) in the Acute Phase of Spinal Cord Injury

Importance:
Page Updated: September 21, 2026
IR Disclosure Date: July 24, 2026
Other

Kringle Pharma, Inc.

Company overview · Stock price · Financial data · All IR

View company page →